Date: 2014-07-24
Type of information: Collaboration agreement
Compound: Next-Generation Sequencing, Genotyping and Drug Resistance Products
Company: Roche (Switzerland) Advanced Biological Laboratories (Luxembourg)
Therapeutic area: Diagnostic - Infectious diseases
Type agreement: collaboration
Action mechanism:
Disease: hepatitis B, hepatitis C, HIV
Details: * On July 24, 2014, Advanced Biological Laboratories (ABL), a Medical Data Technology company founded in 2000 as a spin-off from CRP-Santé Luxembourg, announced the renewal of a non-exclusive collaboration agreement with Roche Diagnostics International for Europe, Middle East, Africa (EMEA) and Latin America (LATAM) territories. This collaboration agreement is intended to develop a strategy to promote ABL products especially its next-generation sequencing platform DeepChek® together with Roche’s next generation sequencing systems (GS Junior and GS FLX+ Sequencing Systems) for molecular virology. The principal objectives of the collaboration are to provide our mutual customers with integrated sequencing and analysis systems delivering the required quality, sensitivity and meaningful genotyping and drug resistance reporting for personalized healthcare.The collaboration has been extended from HIV to viral hepatitis B and C. * On September 10, 2013, Advanced Biological Laboratories (ABL) announced the signing of a non-exclusive collaboration agreement with Roche Diagnostics International for Europe, Middle East, Africa (EMEA) and Latin America (LATAM) territories. This collaboration agreement is intended to develop a strategy to promote ABL products especially its next-generation sequencing platform DeepChek® together with Roche’s Next Generation Sequencing systems (GS Junior and GS FLX+ systems) for molecular virology. The principal objectives of the Collaboration are to provide mutual customers with integrated sequencing and analysis systems delivering the required quality, sensitivity and meaningful genotyping and drug resistance reporting for personalized healthcare.
Financial terms:
Latest news:
